A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to assess the possible withdrawal effects after abruptly
stopping daily therapy with dapoxetine compared with continuing daily therapy in men with
premature ejaculation (PE).
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.